Stuart Bryan 4
4 · Fulcrum Therapeutics, Inc. · Filed Jan 27, 2021
Insider Transaction Report
Form 4
Stuart Bryan
Chief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2021-01-25+134,376→ 134,376 totalExercise: $13.09Exp: 2031-01-24→ Common Stock (134,376 underlying)
Footnotes (1)
- [F1]This option was granted on January 25, 2021 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2021, subject to continued service.